Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non–Small Cell Lung Cancer

by Lin, Jessica J., Chin, Emily, Yeap, Beow Y., Ferris, Lorin A., Kamesan, Vashine, Lennes, Inga T., Sequist, Lecia V., Heist, Rebecca S., Mino-Kenudson, Mari, Gainor, Justin F., Shaw, Alice T.
Published in Journal of thoracic oncology

Acquired Resistance to First-Line Afatinib and the Challenges of Prearranged Progression Biopsies

by Campo, Meghan, Gerber, David, Gainor, Justin F., Heist, Rebecca S., Temel, Jennifer S., Shaw, Alice T., Fidias, Panos, Muzikansky, Alona, Engelman, Jeffrey A., Sequist, Lecia V.
Published in Journal of thoracic oncology

Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival

by Yuan, Qianyu, Du, Mulong, Loehrer, Elizabeth, Johnson, Bruce E, Gainor, Justin F, Lanuti, Michael, Li, Yi, Christiani, David C
Published in Cancer epidemiology, biomarkers & prevention

Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer

by Lichtenstein, Morgan R.L., Nipp, Ryan D., Muzikansky, Alona, Goodwin, Kelly, Anderson, Danyon, Newcomb, Richard A., Gainor, Justin F.
Published in Journal of thoracic oncology

Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC

by Dagogo-Jack, Ibiayi, Rooney, Marguerite, Nagy, Rebecca J., Lin, Jessica J., Chin, Emily, Ferris, Lorin A., Ackil, Jennifer, Lennerz, Jochen K., Lanman, Richard B., Gainor, Justin F., Shaw, Alice T.
Published in Journal of thoracic oncology

Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity

by Strickland, Matthew R, Alvarez-Breckenridge, Christopher, Gainor, Justin F, Brastianos, Priscilla K
Published in Cancer discovery

Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping

by Heist, Rebecca S., Sequist, Lecia V., Borger, Darrell, Gainor, Justin F., Arellano, Ronald S., Le, Long P., Dias-Santagata, Dora, Clark, Jeffrey W., Engelman, Jeffrey A., Shaw, Alice T., Iafrate, A. John
Published in Journal of thoracic oncology

Clinical Activity of Alectinib in Advanced RET-Rearranged Non–Small Cell Lung Cancer

by Lin, Jessica J., Kennedy, Elizabeth, Sequist, Lecia V., Brastianos, Priscilla K., Goodwin, Kelly E., Stevens, Sara, Wanat, Alexandra C., Stober, Lisa L., Digumarthy, Subba R., Engelman, Jeffrey A., Shaw, Alice T., Gainor, Justin F.
Published in Journal of thoracic oncology

Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience

by Mooradian, Meghan J., Nasrallah, Mazen, Gainor, Justin F., Reynolds, Kerry L., Cohen, Justine V., Lawrence, Donald P., Miloslavsky, Eli M., Kohler, Minna J., Sullivan, Ryan J., Schoenfeld, Sara R.
Published in Seminars in arthritis and rheumatism

Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non-Small Cell Lung Cancer

by Lopez de Rodas, Miguel, Wang, Yvonne, Peng, Gang, Gu, Jianlei, Mino-Kenudson, Mari, Riess, Jonathan W, Velcheti, Vamsidhar, Hellmann, Matthew, Gainor, Justin F, Zhao, Hongyu, Schalper, Kurt A
Published in Clinical cancer research

ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study

by Johnson, Melissa, Dudek, Arkadiusz Z, Sukari, Ammar, Call, Justin, Kunk, Paul R, Lewis, Karl, Gainor, Justin F, Sarantopoulos, John, Lee, Patrice, Golden, Adele, Harney, Allison, Rothenberg, S Michael, Zhang, Yuanyuan, Goldman, Jonathan W
Published in Clinical cancer research

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases

by Uruga, Hironori, Bozkurtlar, Emine, Huynh, Tiffany G., Muzikansky, Alona, Goto, Yasushi, Gomez-Caraballo, Maria, Hata, Aaron N., Gainor, Justin F., Mark, Eugene J., Engelman, Jeffrey A., Lanuti, Michael D., Mino-Kenudson, Mari
Published in Journal of thoracic oncology

Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-es...

by Lakhani, Nehal J, Chow, Laura Q M, Gainor, Justin F, LoRusso, Patricia, Lee, Keun-Wook, Chung, Hyun Cheol, Lee, Jeeyun, Bang, Yung-Jue, Hodi, Frank Stephen, Kim, Won Seog, Santana-Davila, Rafael, Fanning, Philip, Squifflet, Pierre, Jin, Feng, Kuo, Tracy C, Wan, Hong I, Pons, Jaume, Randolph, Sophia S, Messersmith, Wells A
Published in The lancet oncology

KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

by Krall, Elsa B, Wang, Belinda, Munoz, Diana M, Ilic, Nina, Raghavan, Srivatsan, Niederst, Matthew J, Yu, Kristine, Ruddy, David A, Aguirre, Andrew J, Kim, Jong Wook, Redig, Amanda J, Gainor, Justin F, Williams, Juliet A, Asara, John M, Doench, John G, Janne, Pasi A, Shaw, Alice T, McDonald Iii, Robert E, Engelman, Jeffrey A, Stegmeier, Frank, Schlabach, Michael R, Hahn, William C
Published in eLife

Current opportunities and challenges in ALK-positive lung cancer

by Lin, Jessica J., Gainor, Justin F.
Published in Translational lung cancer research

ATLANTIC: a sea change in immunotherapy for oncogene-driven lung cancer?

by Lin, Jessica J, Gainor, Justin F
Published in The lancet oncology

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

by Shaw, Alice T, Dr, Yeap, Beow Y, ScD, Solomon, Benjamin J, MD, Riely, Gregory J, MD, Gainor, Justin, MD, Engelman, Jeffrey A, MD, Shapiro, Geoffrey I, MD, Costa, Daniel B, MD, Ou, Sai-Hong I, MD, Butaney, Mohit, BS, Salgia, Ravi, Prof, Maki, Robert G, MD, Varella-Garcia, Marileila, Prof, Doebele, Robert C, MD, Bang, Yung-Jue, Prof, Kulig, Kimary, PhD, Selaru, Paulina, MSPH, Tang, Yiyun, PhD, Wilner, Keith D, PhD, Kwak, Eunice L, MD, Clark, Jeffrey W, MD, Iafrate, A John, MD, Camidge, D Ross, MD
Published in The lancet oncology

Response to Provenzano et al. and De Carlo et al

by Kalchiem-Dekel, Or, Bestvina, Christine M., Gainor, Justin F., Drilon, Alexander, Lin, Jessica J.
Published in Journal of thoracic oncology

Square peg, round hole? Programmed death-1 inhibitors in epidermal growth factor receptor-mutant non-small cell lung cancer

by Gainor, Justin F
Published in Journal of thoracic disease

High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities

by Roh, Whijae, Geffen, Yifat, Cha, Hongui, Miller, Mendy, Anand, Shankara, Kim, Jaegil, Heiman, David I, Gainor, Justin F, Laird, Peter W, Cherniack, Andrew D, Ock, Chan-Young, Lee, Se-Hoon, Getz, Gad
Published in Cancer research (Chicago, Ill.)